 |
Articles: Chemotherapy/Oncology |
Prior Articles
Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status
Lung Cancer, 10/30/09
Expression of ERCC1 and class IIIbeta tubulin for predicting effect of carboplatin/paclitaxel in patients with advanced inoperable non-small cell lung cancer
Pathology International, 10/30/09 Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure
Pharmacogenetics and genomics, 10/30/09 Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Trends in Pharmacological Sciences, 10/29/09 The role of surveillance in the treatment of patients with muscle-invasive bladder cancer after chemotherapy
BJU International, 10/29/09 A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer
Cancer Chemotherapy and Pharmacology, 10/29/09 Cisplatin administration following carboplatin desensitization failure in primary peritoneal cancer: a brief report
Cancer Chemotherapy and Pharmacology, 10/28/09 Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial
British Medical Journal, 10/28/09
Free full text
Adjuvant Chemotherapy in Localized Soft Tissue Sarcomas: Still Not Proven
The Oncologist, 10/28/09 Bendamustine: A New Treatment Option for Chronic Lymphocytic Leukemia
Pharmacotherapy, 10/27/09 Management of Venous Thromboembolism and the Potential to Impact Overall Survival in Patients with Cancer
Pharmacotherapy, 10/27/09 Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma
The Journal of Thoracic and Cardiovascular Surgery, 10/27/09 Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan
Pharmacoepidemiology and Drug Safety, 10/27/09 Arsenic trioxide as first-line treatment for acute promyelocytic leukemia
American Journal of Health-System Pharmacy, 10/26/09 Proteasome Inhibitors in Cancer Therapy
Current Drug Targets, 10/23/09 Efficacy and Safety of the Combination of Docetaxel with Targeted Therapies in the Treatment of Solid Malignancies
Current Drug Targets, 10/23/09 Anti-Egfr Therapy in Colorectal Cancer: How to Choose The Right Patient
Current Drug Targets, 10/23/09 Phase I trial of vinflunine and pemetrexed in refractory solid tumors
Investigational New Drugs, 10/23/09 Drug Targeting Through Pilosebaceous Route
Current Drug Targets, 10/23/09 Targeting Sarcomas: Novel Biological Agents and Future Perspectives
Current Drug Targets, 10/23/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
